These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37206100)

  • 1. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
    Khan S; Fawaz S; Simpson R; Robertson C; Kelly P; Mohdnazri S; Tang K; Cook CM; Gallagher S; O'Kane P; Spratt J; Brilakis ES; Karamasis GV; Al-Lamee R; Keeble TR; Davies JR
    Front Cardiovasc Med; 2023; 10():1172763. PubMed ID: 37206100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial.
    Nowbar AN; Rajkumar C; Foley M; Ahmed-Jushuf F; Howard JP; Seligman H; Petraco R; Sen S; Nijjer SS; Shun-Shin MJ; Keeble TR; Sohaib A; Collier D; McVeigh P; Harrell FE; Francis DP; Al-Lamee RK
    EuroIntervention; 2022 Apr; 17(18):1490-1497. PubMed ID: 35156616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
    Nowbar AN; Francis DP; Al-Lamee RK
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1011-1018. PubMed ID: 34417901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
    Al-Lamee R; Thompson D; Dehbi HM; Sen S; Tang K; Davies J; Keeble T; Mielewczik M; Kaprielian R; Malik IS; Nijjer SS; Petraco R; Cook C; Ahmad Y; Howard J; Baker C; Sharp A; Gerber R; Talwar S; Assomull R; Mayet J; Wensel R; Collier D; Shun-Shin M; Thom SA; Davies JE; Francis DP;
    Lancet; 2018 Jan; 391(10115):31-40. PubMed ID: 29103656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original Article--Value of Pathological Q Waves and Angiographic Collateral Grade in Patients Undergoing Coronary Chronic Total Occlusion Recanalization: Cardiac Magnetic Resonance Study.
    Shokry KA; Farag EM; Salem AM; Ibrahim IM; Abel-Aziz M; El Zayat A
    J Saudi Heart Assoc; 2021; 33(1):41-50. PubMed ID: 33880327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status.
    Peri-Okonny PA; Spertus JA; Grantham JA; Gosch K; Kirtane A; Sapontis J; Lombardi W; Karmpaliotis D; Moses J; Nicholson W; Salisbury AC
    J Am Heart Assoc; 2019 Apr; 8(7):e011629. PubMed ID: 30922149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anginal medication titration among patients with residual angina 6-months after chronic total occlusion percutaneous coronary intervention: insights from OPEN CTO registry.
    Sheehy JP; Qintar M; Arnold SV; Hirai T; Sapontis J; Jones PG; Tang Y; Lombardi W; Karmpaliotis D; Moses JW; Patterson C; Cohen DJ; Amin AP; Nicholson WJ; Spertus JA; Grantham JA; Salisbury AC
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):370-379. PubMed ID: 30895291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
    Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Nowbar AN; Simader FA; Davies JR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Gamma R; Clesham G; Williams R; Din J; Nijjer SS; Curzen N; Ruparelia N; Sinha M; Dungu JN; Ganesananthan S; Khamis R; Mughal L; Kinnaird T; Petraco R; Spratt JC; Sen S; Sehmi J; Collier DJ; Sohaib A; Keeble TR; Cole GD; Howard JP; Francis DP; Shun-Shin MJ; Al-Lamee RK;
    N Engl J Med; 2023 Dec; 389(25):2319-2330. PubMed ID: 38015442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: The CARISMA_CTO study design.
    Pica S; Di Giovine G; Bollati M; Testa L; Bedogni F; Camporeale A; Pontone G; Andreini D; Monti L; Gasparini G; Grancini L; Secco GG; Maestroni A; Ambrogi F; Milani V; Lombardi M
    Int J Cardiol; 2018 Dec; 272():356-362. PubMed ID: 30173921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina.
    Hirai T; Grantham JA; Sapontis J; Cohen DJ; Marso SP; Lombardi W; Karmpaliotis D; Moses J; Nicholson WJ; Pershad A; Wyman RM; Spaedy A; Cook S; Doshi P; Federici R; Nugent K; Gosch KL; Spertus JA; Salisbury AC
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007558. PubMed ID: 30871356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial - rationale and design.
    Råmunddal T; Holck EN; Karim S; Eftekhari A; Escaned J; Ioanes D; Walsh S; Spratt J; Veien K; Jensen LO; Tilsted HH; Terkelsen CJ; Havndrup O; Olsen NT; Kajander OA; Faurie B; Lanematt P; Jakobsen L; Christiansen EH
    Am Heart J; 2023 Mar; 257():41-50. PubMed ID: 36423733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO).
    Juricic SA; Stojkovic SM; Galassi AR; Stankovic GR; Orlic DN; Vukcevic VD; Milasinovic DG; Aleksandric SB; Tomasevic MV; Dobric MR; Nedeljkovic MA; Beleslin BD; Dikic MP; Banovic MD; Ostojic MC; Tesic MB
    Front Cardiovasc Med; 2022; 9():1014664. PubMed ID: 36698926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of visualization of successful revascularization on chest pain and quality of life in chronic coronary syndrome: study protocol for the multi-center, randomized, controlled PLA-pCi-EBO-pilot-trial.
    Wester M; Koll F; Zeman F; Dempfle A; Koller M; Frey N; Maier LS; Sossalla S
    Trials; 2020 Oct; 21(1):838. PubMed ID: 33032655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Ganesananthan S; Rajkumar CA; Foley M; Thompson D; Nowbar AN; Seligman H; Petraco R; Sen S; Nijjer S; Thom SA; Wensel R; Davies J; Francis D; Shun-Shin M; Howard J; Al-Lamee R
    Eur Heart J; 2022 Sep; 43(33):3132-3145. PubMed ID: 35639660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.
    Yeh RW; Tamez H; Secemsky EA; Grantham JA; Sapontis J; Spertus JA; Cohen DJ; Nicholson WJ; Gosch K; Jones PG; Valsdottir LR; Bruckel J; Lombardi WL; Jaffer FA
    JACC Cardiovasc Interv; 2019 Apr; 12(7):651-658. PubMed ID: 30878475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Coronary Intervention of Coronary Chronic Total Occlusions Improves Peak Oxygen Uptake During Cardiopulmonary Exercise Testing.
    Abdullah SM; Hastings JL; Amsavelu S; Garcia-Morales F; Hendrix F; Karatasakis A; Danek BA; Karacsonyi J; Rangan BV; Roesle M; Khalili H; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Mar; 29(3):83-91. PubMed ID: 28255103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions.
    Wijeysundera HC; Norris C; Fefer P; Galbraith PD; Knudtson ML; Wolff R; Wright GA; Strauss BH; Ko DT
    EuroIntervention; 2014 Feb; 9(10):1165-72. PubMed ID: 24561733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader FA; Chotai S; Pathimagaraj RH; Mohsin M; Salih A; Wang D; Dixit P; Davies JR; Keeble TR; Cosgrove C; Spratt JC; O'Kane PD; De Silva R; Hill JM; Nijjer SS; Sen S; Petraco R; Mikhail GW; Khamis R; Kotecha T; Harrell FE; Kellman P; Francis DP; Howard JP; Cole GD; Shun-Shin MJ; Al-Lamee RK
    Lancet; 2024 Apr; 403(10436):1543-1553. PubMed ID: 38604209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
    Simader FA; Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Chotai S; Bual N; Khokhar A; Gohar A; Lampadakis I; Ganesananthan S; Pathimagaraj RH; Nowbar A; Davies JR; Keeble TR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Spratt JC; Williams R; Nijjer SS; Sen S; Curzen N; Sinha M; Howard JP; Cole G; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK;
    J Am Coll Cardiol; 2024 Jul; 84(1):13-24. PubMed ID: 38759906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.